Literature DB >> 24356938

Percutaneous closure of a gigantic patent ductus arteriosus (PDA) with pulmonary hypertension with an atrial septal defect occluder in a 35-year-old woman.

Michael Froehle1, Nikolaus A Haas, Eugen Sandica, Christoph Happel, Kai Thorsten Laser.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24356938     DOI： 10.1007/s00392-013-0650-6

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  12 in total

1.  Transcatheter closure of a 16 mm hypertensive patent ductus arteriosus with the Amplatzer muscular VSD occluder.

Authors:  M Demkow; W Ruzyllo; H Siudalska; C Kepka
Journal:  Catheter Cardiovasc Interv       Date:  2001-03       Impact factor: 2.692

2.  Closure of the patent ductus arteriosus with the amplatzer PDA device: immediate results of the international clinical trial.

Authors:  H J Faella; Z M Hijazi
Journal:  Catheter Cardiovasc Interv       Date:  2000-09       Impact factor: 2.692

3.  ESC Guidelines for the management of grown-up congenital heart disease (new version 2010).

Authors:  Helmut Baumgartner; Philipp Bonhoeffer; Natasja M S De Groot; Fokko de Haan; John Erik Deanfield; Nazzareno Galie; Michael A Gatzoulis; Christa Gohlke-Baerwolf; Harald Kaemmerer; Philip Kilner; Folkert Meijboom; Barbara J M Mulder; Erwin Oechslin; Jose M Oliver; Alain Serraf; Andras Szatmari; Erik Thaulow; Pascal R Vouhe; Edmond Walma
Journal:  Eur Heart J       Date:  2010-08-27       Impact factor: 29.983

Review 4.  Interventional treatment of patent ductus arteriosus in 2004.

Authors:  John W Moore; Daniel S Levi; Sarah D Moore; Douglas J Schneider; Farhouch Berdjis
Journal:  Catheter Cardiovasc Interv       Date:  2005-01       Impact factor: 2.692

5.  Transcatheter closure of a 22 mm patent ductus arteriosus with an Amplatzer atrial septal occluder.

Authors:  Christian Spies; Franz Ujivari; Rainer Schräder
Journal:  Catheter Cardiovasc Interv       Date:  2005-03       Impact factor: 2.692

6.  Transcatheter closure of a non-restrictive patent ductus arteriosus with an Amplatzer muscular ventricular septal defect occluder.

Authors:  Andreas Eicken; Gunter Balling; Hans Peter Gildein; Thomas Genz; Harald Kaemmerer; John Hess
Journal:  Int J Cardiol       Date:  2006-12-29       Impact factor: 4.164

7.  Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study.

Authors:  Zhen-Ning Zhang; Xin Jiang; Rui Zhang; Xin-Li Li; Bing-Xiang Wu; Qin-Hua Zhao; Yong Wang; Li-Zhi Dai; Lei Pan; Mardi Gomberg-Maitland; Zhi-Cheng Jing
Journal:  Heart       Date:  2011-09-21       Impact factor: 5.994

8.  Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.

Authors:  Nazzareno Galiè; Maurice Beghetti; Michael A Gatzoulis; John Granton; Rolf M F Berger; Andrea Lauer; Eleonora Chiossi; Michael Landzberg
Journal:  Circulation       Date:  2006-06-26       Impact factor: 29.690

9.  Frequency and spectrum of congenital heart defects among live births in Germany : a study of the Competence Network for Congenital Heart Defects.

Authors:  Gerda Schwedler; Angelika Lindinger; Peter E Lange; Ulrich Sax; Julianna Olchvary; Brigitte Peters; Ulrike Bauer; Hans-Werner Hense
Journal:  Clin Res Cardiol       Date:  2011-09-10       Impact factor: 5.460

10.  The effect of amlodipine on exercise-induced pulmonary hypertension and right heart function in patients with chronic obstructive pulmonary disease.

Authors:  I W Franz; Jochen Van Der Meyden; S Schaupp; Ulrich Tönnesmann
Journal:  Z Kardiol       Date:  2002-10
View more
  2 in total

1.  Safety and Outcomes of Transcatheter Closure of Patent Ductus Arteriosus in Children With Pulmonary Artery Hypertension.

Authors:  Arash Salavitabar; Usha S Krishnan; Mariel E Turner; Julie A Vincent; Alejandro J Torres; Matthew A Crystal
Journal:  Tex Heart Inst J       Date:  2020-08-01

2.  Outcomes of transcatheter closure of patent ductus arteriosus with the off-label use of large occluders (≥16 mm).

Authors:  Kewal Kanabar; Dinakar Bootla; Navjyot Kaur; C R Pruthvi; Darshan Krishnappa; Krishna Santosh; Vivek Guleria; Manoj Kumar Rohit
Journal:  Indian Heart J       Date:  2020-04-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.